Feasibility of laparoscopic portal vein ligation prior to major hepatectomy  by Are, C. et al.
REVIEW ARTICLE
Feasibility of laparoscopic portal vein ligation prior to major
hepatectomy
C. ARE1, S. IACOVITTI2, F. PRETE3 & F. M. CRAFA3
1Department of Surgery, Eppley Cancer Centre, Division of Surgical Oncology, University of Nebraska Medical Centre,
Omaha, USA, 2Madre Guiseppina Vannini Hospital, Surgery, via della acqua bullicante, Rome, Italy and 3University of
Foggia, Surgery, Foggia, Italy
Abstract
Background. Patients noted to have an inadequate future liver remnant on pre operative volumetric assessment are
considered to be candidates for portal vein embolization (PVE). A subset of patients undergo laparoscopic intervention
prior to PVE for staging purposes or to address the primary in Stage IV colon cancer. These patients usually undergo PVE
as a subsequent additional procedure by the transhepatic route. The aim of this study was to assess the feasibility of portal
vein ligation by the laparoscopic approach in suitable patients. Materials and methods. A retrospective review of a
prospectively maintained database was performed to identify patients that underwent laparoscopic portal vein ligation
(LPVL). The demographic, clinical, radiographic, operative and volumetric details were collected to determine the
feasibility of portal vein ligation. Results. A total of nine patients underwent LPVL as part of a two stage procedure in
preparation for subsequent major hepatectomy. With a median age of 67 yrs, the diagnoses included: colorectal metastasis
(five patients), cholangiocarcinoma (three patients) and hepatocellular carcinoma (one patient). The ligation involved the
right portal vein in all and was performed with silk ligature (seven patients) and clips (two patients). Volumetric data was
available in six patients which showed a mean increase from 209.1 cc997.76 to 495.83 cc9310.91 (increase by 181.5%) In
two patients, inadequate hypertrophy mandated later embolization by percutaneous technique. Five patients underwent
subsequent major hepatic resection as planned. The remaining four patients were noted to have progression of disease that
precluded the planned procedure. There were no complications associated with LPVL. Conclusions. LPVL is feasible and
can be safely performed. In a select group of patients, it may be considered as an alternative to subsequent embolization and
thereby potentially absolve the need for an additional procedure with its attendant complications.
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Introduction
Portal vein occlusion (embolization/ligation) is under-
taken in patients with an inadequate future liver
remnant (FLR) prior to planned subsequent major
hepatectomy [13]. In the majority of patients the
decision to proceed with portal vein occlusion is made
on pre operative volumetric assessment and the
patients then undergo portal vein embolization
(PVE). A subset of patients are determined to be
candidates for portal vein occlusion during staging
laparoscopy when unexpected bilobar involvement is
detected [47]. In addition, patients with colorectal
cancer and synchronous hepatic involvement that are
taken to the operating room for laparoscopic resection
of the primary could be potential candidates for portal
vein occlusion. These patients are usually subjected to
PVE as a separate procedure at a subsequent stage.
The ability to ligate the portal vein at the same time as
laparoscopy in eligible patients could potentially avoid
another procedure in the future with its attendant
complications. The aim of this study was to assess the
feasibility of laparoscopic portal vein ligation (LPVL)
in suitable patients at the same time as the initial
laparoscopy.
Materials and methods
All patients who underwent LPVL for hepatobiliary
malignancies were identified from a prospectively
maintained database (11/2005 to 06/2007). Data
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relating to patient demographics, primary diagnosis
and extent of hepatic involvement on CT scan was
collected. LPVL was performed as described.
The patient is placed supine on the operating table
with the positioning of trocars as shown in Figure 1.
Access to the abdomen was gained by the Hasson
technique and the pneumoperitoneum was main-
tained at 12 mmHg. After performing diagnostic
laparoscopy, the need for portal vein ligation was
determined in each patient based on the combination
of pre operative radiological and intra op findings. An
intra op ultra sound examination of the liver was
performed in all patients.
The portal triad was dissected from the right side
with the help of harmonic scalpel. The bile duct was
dissected and elevated to expose the main portal vein.
Further dissection was performed in the cranial
direction to identify the portal bifurcation. The right
portal vein was now dissected and encircled with a
vessel loop. The right portal vein was now occluding
with either clips or silk ligature. The details of
additional procedures, performed at the same time
as LPVL, mortality, morbidity and post operative
course was obtained.
The extent of hepatic involvement was assessed on
CT scan prior to LPVL. The majority of patients
underwent CT scan 36 weeks after LPVL with some
undergoing CT scan 78 weeks afterwards. The
degree of hypertrophy (DOH) was assessed by
performing volumetric assessments on the pre and
post LPVL scans (Figures 2 and 3). Volumetric
measurements were performed by a radiologist by
comparing the volume of the FLR before and after
LPVL. The volume of the FLR was calculated by the
following formula: remnant liver volume100}(to-
tal liver volume minus tumor volume). The percent
change in size or DOH of the FLR was calculated by
the following formula: DOH(FLR volume: post
LPVL) minus (FLR volume: pre LPVL)}(FLR
volume: pre PVL)100.
Results
A total of nine patients underwent LPVL for various
hepatobiliary malignancies. The patient demographics
Figure 1. Position of trocars.
Figure 2. CT Scan prior to laproscopic portal vein ligation.
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and clinical details are shown in Table I. Colorectal
metastasis accounted for 55% of the patients included
in the study. One patient with colorectal metastasis
received chemotherapy prior to LPVL.
The right portal vein was ligated in all patients.
Metallic clips were used in two patients and silk
ligature (20 silk) was used in the subsequent seven
patients to occlude the right portal vein. Seven
patients underwent other hepatic procedures such as
wedge excision of lesions in the left lobe, biopsy of
portal lymph nodes and cholecystectomy at the same
time as LPVL (Table I). In three patients, simulta-
neous resection of the colorectal primary was per-
formed. The mortality rate was zero and there were
no morbidities related to LPVL. The mean length of
stay was 6.7 days (91.4). After excluding the patients
who underwent a simultaneous colorectal procedure,
the mean length of stay was 3.5 days (91.4).
The extent of hepatic involvement prior to LPVL is
shown in Table I. All the patients had extensive
involvement of the right lobe of the liver. The caudate
lobe and the left lateral segment were involved in three
patients. In patients with involvement of the left
lateral segment, wedge excision was performed simul-
taneously with LPVL.
Volumetric data was available in six patients of
whom three patients did not undergo the planned
subsequent major hepatic rescection. In these three
patients volumetric data was performed beyond the
customary four week period (Table II). The pre
operative mean volume for all six patients was
209.1997.76. Post LPVL volumes increased to a
mean of 495.839310.91. The mean difference in
volume between pre and post LPVL was 286.839
313.94. The difference in volume ranged from
22 ml to 877 ml. The mean DOH was 181.5%. The
Figure 3. CT Scan post laproscopic portal vein ligation.
Table I. Demographics and clinical details of nine patients included in the study.
Pt # Age Sex Diagnosis Extent of hepatic involvement Other hepatic procedure Extra hepatic procedure
1 49 M CLM III, IV, VI, VII, VIII Wedge excision seg III
biopsy PLN
None
2 59 M CCA I, IV (single lesion, size6.5 cm None None
3 72 F CCA I, VI, VII Biopsy PLN None
4 62 M CLM IV, V, VI, VII, VIII (single lesion
measuring 12 cm)
Cholecystectomy None
5 77 M HCC Extensive involvement of right lobe Cholecystectomy None
6 67 M CLM Multiple lesions in entire right liver
and lesion in II, III
Wedge excision x 2-left lobe Laparoscopic LAR
7 73 M CLM III, IV, V, VI, VII Wedge excision seg III Laparoscopic left Hemicolectomy
8 49 M CLM Multiple lesions in entire right liver None Laparoscopic LARTME
ileostomyportacath
9 75 M CCA I, IV, VII, VIII Cholecystectomy None
CLMcolorectal liver metastasis; CCAcholangiocarcinoma; HCChepatocellular carcinoma; PLNportal lymph nodes; LARlow
anterior resection; TMEtotal mesorectal excision.
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maximal DOH was noted in patient # 9 (423%) with
a diagnosis of cholangiocarcinoma.
Five patients (55%) underwent a subsequent major
hepatectomy as planned. Three patients underwent a
right hepatectomy and two patients required an
extended right hepatectomy to obtain a R0 resection.
The caudate lobe was resected in two patients. In
patient #1 there was evidence of new lesions (B1cm)
on the non-embolized side that required wedge
resections. The remaining four patients were noted
to have progression of disease that precluded the
planned major hepatectomy.
Discussion
Portal vein occlusion has become an integral compo-
nent in the treatment algorithm of patients with
inadequate FLR [13]. Portal vein occlusion redirects
blood to the FLR and has been shown to reduce the
risk of complications due to peri operative liver failure
[13]. This is usually accomplished by the technique
of PVE which was initially described by Makucchi et
al. in 1984 [8] and substantiated in a later report in
1990 [9] for patients with cholangiocarcinoma. Ki-
noshita et al. described the similar technique in
patients with hepatocellular carcinoma in 1986 [10].
The clinical benefit of PVE have been documented in
patients with colorectal hepatic metastasis [1113]
and hepatocellular carcinoma [1416]. Although PVE
is the preferred choice by many, a role for PVL has
also been demonstrated by some authors [1719].
The decision to occlude the portal vein is usually
based on pre operative volumetric assessment of the
FLR. These patients are subjected to PVE through
the ipsilateral or contralateral liver lobe by the
transhepatic approach. A subset of patients who are
candidates for staged hepatectomy undergo laparo-
scopic intervention prior to PVE. This includes
patients with Stage IV colon cancer who are taken
to the operating room for laparoscopic resection of the
primary. In addition, some patients are determined to
be candidates for staged hepatic resection at the time
of staging laparoscopy [47]. These patients undergo
PVE as an additional procedure at a later stage. The
ability to ligate the portal vein at the time of initial
laparoscopy could potentially avoid this additional
procedure. The aim of this study was to assess
feasibility of LPVL in patients with various hepato-
biliary malignancies.
The results of our study demonstrate that LPVL is
feasible in a select group of patients. There were no
complications in relation to LPVL. In patients requir-
ing laparoscopic resection of the colorectal primary,
simultaneous LPVL did not lead to increased mor-
bidity. Laparoscopy also enabled us to perform wedge
resections of tumors in the FLR at the time of LPVL.
LPVL was associated with acceptable DOH (increase
in volume of FLR by 181.5%). Five patients (55%)
underwent a subsequent major hepatectomy as
planned. The evidence of progression of disease
precluded a major hepatectomy in the remaining
four patients.
There are some potential advantages to the ap-
proach of LPVL. Portal vein ligation at the time of
laparoscopy avoids a subsequent second procedure.
LPVL can also avoid the morbidity that is associated
with PVE. PVE is known to be associated with several
technical and liver related complications [20,21]. The
rate of complications associated with PVE has been
reported to be in the range of 12.815% [20,21]. The
complications associated with PVE include, haemo-
bilia, haemoperitoneum, arterial puncture, puncture
site haematomas, subcapsular haematomas, pseudoa-
neurysm, pneuomothorax, migration of embolic ma-
terial to FLR, occlusion of main portal vein,
arteriovenous and arterioportal fistulas.
Some authors have suggested that PVE in the
presence of disease in the FLR can lead to dispropor-
tionate hypertrophy of the tumors in relation to
normal liver [22,23]. Elias et al. [22] noted that in
patients with functionally intact liver parenchyma, the
growth rate of metastasis was more rapid than that of
the normal liver. The ability to resect minimal disease
in the FLR at the same time as LPVL could
potentially decrease the risk of disease progression.
Another advantage of laparoscopic PVL is that it does
not preclude subsequent PVE if required. Failure to
undergo hypertrophy following ligation can be seen in
Table II. Volumetric data.
Volumetric data
Patient # Diagnosis Pre op (ml) Post op (ml) Difference in volume (ml) DOH (%)
1 CLM 218.6 1095 877 401
2 CCA 349 510 161 46
3 CCA 223 245 22 10
6 CLM 106 292 186 175
7 CLM 267 357 90 34
9 CCA 91 476 385 423
Mean (9SD) 209.1997.76 495.839310.91 286.839313.94 181.5
CLMcolorectal liver metastasis; CCAcholangiocarcinoma; DOHdegree of hypertrophy.
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patients with variations in right portal vein anatomy
which has been noted to be present in 17% of
patients. Two patients in our study did not demon-
strate adequate DOH of hypertrophy following PVL.
These patients underwent subsequent PVE by the
transhepatic route and were noted to have adequate
DOH.
The results of our study demonstrate the LPVL is
feasible, safe and is associated with acceptable DOH.
This approach may be suitable in a select group of
patients that need to go to the operating room initially
for addressing the primary lesion or staging purposes.
LPVL helps to avoid a subsequent procedure with its
attendant complications. The ability to address mini-
mal disease in the FLR at the same time could also
potentially reduce the risk of disease progression in
the FLR. Therefore, in a select group of patients,
LPVL can be considered as a viable alternative to
PVE.
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